Policy Cures Research and Wellcome have partnered to create a comprehensive database of all snakebite envenoming (SBE) medicines with direct action on snake venom toxins that have either been investigated or been available for clinical use since in 2015.
As of September 2022, this database provides the most up-to-date view of the landscape of available products and investigational candidates for SBE. The platform serves as a much-needed tool to evaluate and prioritise candidates and products under development or in use, with a view to accelerating progress in snakebite therapeutics R&D.
Downloads of the full database are available in Excel.
Available products for snakebite envenoming are listed here and investigational candidates are detailed here.
Our report detailing our findings is available here.
An interactive portal and dashboard of the findings are available below.